Stanford Peng
President en ALPINE IMMUNE SCIENCES, INC. .
Fortuna: 3 M $ al 31/03/2024
Perfil
Stanford L.
Peng is the President & Head-Research & Development at Alpine Immune Sciences, Inc. He previously worked as the Executive Director-Medical at Seagen Inc. from 2014 to 2015, Senior Director at ARYx Therapeutics, Inc. from 2008 to 2009, Chief Medical Officer & Head-Clinical Development at Stemcentrx, Inc. from 2015 to 2016, and Head-Rheumatology Clinical Research Unit at Benaroya Research Institute at Virginia Mason from 2009 to 2014.
He also served as an Assistant Professor at Washington University School of Medicine from 2002 to 2005.
Dr. Peng completed his undergraduate degree at Stanford University and holds a doctorate from Yale University.
He also obtained graduate and doctorate degrees from Yale School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/01/2024 | 72 371 ( 0.11% ) | 3 M $ | 31/03/2024 |
Cargos activos de Stanford Peng
| Empresas | Cargo | Inicio |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | President | 16/04/2019 |
Antiguos cargos conocidos de Stanford Peng.
| Empresas | Cargo | Fin |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Benaroya Research Institute at Virginia Mason is a non-profit organization that operates as a medical research institute. It conducts reserach for eliminating autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma. The company was founded in 1956 and is headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
| ARYX THERAPEUTICS, INC. | Director/Board Member | 01/01/2009 |
| Washington University School of Medicine | Corporate Officer/Principal | 01/01/2005 |
Formación de Stanford Peng.
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
| Yale School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Benaroya Research Institute at Virginia Mason is a non-profit organization that operates as a medical research institute. It conducts reserach for eliminating autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma. The company was founded in 1956 and is headquartered in Seattle, WA. | Commercial Services |
- Bolsa de valores
- Insiders
- Stanford Peng
